Discoverx

Discoverx is a company that provides products and services for drug discovery and development. Founded in 1999, it has focused on developing innovative tools and technologies to accelerate the identification and validation of new therapeutic targets and drug candidates. Their offerings span various areas of life sciences research, including biochemical and cellular assays, screening services, and custom assay development.

The company's core technology platform often involves high-throughput screening (HTS) capabilities, enabling researchers to rapidly test large numbers of compounds for biological activity. Discoverx also offers a range of assay kits and reagents designed to study specific biological pathways and targets, such as those involved in oncology, neuroscience, and immunology. Their services are utilized by pharmaceutical companies, biotechnology firms, and academic research institutions worldwide.

Discoverx has a history of strategic partnerships and collaborations with other organizations in the life sciences sector. In 2017, the company was acquired by Eurofins Scientific, a global leader in bioanalytical testing. Following this acquisition, the Discoverx portfolio and expertise were integrated into Eurofins' broader drug discovery services. This integration aimed to enhance Eurofins' capabilities in areas like target identification, lead optimization, and biomarker discovery.